Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations

Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of medical sciences 2019-01, Vol.16 (3), p.450-460
Hauptverfasser: Abdullah, Mardiaty Iryani, Junit, Sarni Mat, Ng, Khoon Leong, Jayapalan, Jaime Jacqueline, Karikalan, Barani, Hashim, Onn Haji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 460
container_issue 3
container_start_page 450
container_title International journal of medical sciences
container_volume 16
creator Abdullah, Mardiaty Iryani
Junit, Sarni Mat
Ng, Khoon Leong
Jayapalan, Jaime Jacqueline
Karikalan, Barani
Hashim, Onn Haji
description Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.
doi_str_mv 10.7150/ijms.29935
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6428975</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2197900345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-9d8e66705c3d80f4a972ad186de7a4d8841e0f0e55e2d87f4985cfe62024ac63</originalsourceid><addsrcrecordid>eNpVkVFPwjAUhRujEURf_AFmj8YEbLtuXX0wQaJIgtGHvTe1vYPiWLHdSPj3DkGCT7fJ_Xp6eg5C1wQPOEnwvV0sw4AKEScnqEsYE30iMD89OnfQRQgLjGMac3KOOjEWhFAuuij_UCtblspvony-8c6aaKQqDf4hGkMFtdXRsKzBq9q6KkSqMtGbK0E37ZXoybql8l_go0m1hlDb2Q67RGeFKgNc7WcP5S_P-ei1P30fT0bDaV8zxuq-MBmkKceJjk2GC6YEp8qQLDXAFTNZxgjgAkOSADUZL5jIEl1ASjFlSqdxDz3uZFfN5xKMhqr2qpQrb1tXG-mUlf83lZ3LmVvLlNFM8KQVuN0LePfdtB-QSxs0tHFU4JogKRFctKmxLXq3Q7V3IXgoDs8QLLctyG0L8reFFr45NnZA_2KPfwBgboU2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2197900345</pqid></control><display><type>article</type><title>Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Abdullah, Mardiaty Iryani ; Junit, Sarni Mat ; Ng, Khoon Leong ; Jayapalan, Jaime Jacqueline ; Karikalan, Barani ; Hashim, Onn Haji</creator><creatorcontrib>Abdullah, Mardiaty Iryani ; Junit, Sarni Mat ; Ng, Khoon Leong ; Jayapalan, Jaime Jacqueline ; Karikalan, Barani ; Hashim, Onn Haji</creatorcontrib><description>Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.</description><identifier>ISSN: 1449-1907</identifier><identifier>EISSN: 1449-1907</identifier><identifier>DOI: 10.7150/ijms.29935</identifier><identifier>PMID: 30911279</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher</publisher><subject>Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Female ; Goiter, Nodular - complications ; Humans ; Male ; MicroRNAs ; Neoplasm Recurrence, Local - genetics ; Proteomics ; Proto-Oncogene Proteins B-raf - genetics ; Proto-Oncogene Proteins c-ret - genetics ; ras Proteins - genetics ; Review ; Thyroid Cancer, Papillary - diagnosis ; Thyroid Cancer, Papillary - genetics ; Thyroid Cancer, Papillary - therapy ; Thyroid Neoplasms - diagnosis ; Thyroid Neoplasms - genetics ; Thyroid Neoplasms - therapy</subject><ispartof>International journal of medical sciences, 2019-01, Vol.16 (3), p.450-460</ispartof><rights>Ivyspring International Publisher 2019</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-9d8e66705c3d80f4a972ad186de7a4d8841e0f0e55e2d87f4985cfe62024ac63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428975/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428975/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30911279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdullah, Mardiaty Iryani</creatorcontrib><creatorcontrib>Junit, Sarni Mat</creatorcontrib><creatorcontrib>Ng, Khoon Leong</creatorcontrib><creatorcontrib>Jayapalan, Jaime Jacqueline</creatorcontrib><creatorcontrib>Karikalan, Barani</creatorcontrib><creatorcontrib>Hashim, Onn Haji</creatorcontrib><title>Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations</title><title>International journal of medical sciences</title><addtitle>Int J Med Sci</addtitle><description>Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.</description><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Female</subject><subject>Goiter, Nodular - complications</subject><subject>Humans</subject><subject>Male</subject><subject>MicroRNAs</subject><subject>Neoplasm Recurrence, Local - genetics</subject><subject>Proteomics</subject><subject>Proto-Oncogene Proteins B-raf - genetics</subject><subject>Proto-Oncogene Proteins c-ret - genetics</subject><subject>ras Proteins - genetics</subject><subject>Review</subject><subject>Thyroid Cancer, Papillary - diagnosis</subject><subject>Thyroid Cancer, Papillary - genetics</subject><subject>Thyroid Cancer, Papillary - therapy</subject><subject>Thyroid Neoplasms - diagnosis</subject><subject>Thyroid Neoplasms - genetics</subject><subject>Thyroid Neoplasms - therapy</subject><issn>1449-1907</issn><issn>1449-1907</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkVFPwjAUhRujEURf_AFmj8YEbLtuXX0wQaJIgtGHvTe1vYPiWLHdSPj3DkGCT7fJ_Xp6eg5C1wQPOEnwvV0sw4AKEScnqEsYE30iMD89OnfQRQgLjGMac3KOOjEWhFAuuij_UCtblspvony-8c6aaKQqDf4hGkMFtdXRsKzBq9q6KkSqMtGbK0E37ZXoybql8l_go0m1hlDb2Q67RGeFKgNc7WcP5S_P-ei1P30fT0bDaV8zxuq-MBmkKceJjk2GC6YEp8qQLDXAFTNZxgjgAkOSADUZL5jIEl1ASjFlSqdxDz3uZFfN5xKMhqr2qpQrb1tXG-mUlf83lZ3LmVvLlNFM8KQVuN0LePfdtB-QSxs0tHFU4JogKRFctKmxLXq3Q7V3IXgoDs8QLLctyG0L8reFFr45NnZA_2KPfwBgboU2</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Abdullah, Mardiaty Iryani</creator><creator>Junit, Sarni Mat</creator><creator>Ng, Khoon Leong</creator><creator>Jayapalan, Jaime Jacqueline</creator><creator>Karikalan, Barani</creator><creator>Hashim, Onn Haji</creator><general>Ivyspring International Publisher</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190101</creationdate><title>Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations</title><author>Abdullah, Mardiaty Iryani ; Junit, Sarni Mat ; Ng, Khoon Leong ; Jayapalan, Jaime Jacqueline ; Karikalan, Barani ; Hashim, Onn Haji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-9d8e66705c3d80f4a972ad186de7a4d8841e0f0e55e2d87f4985cfe62024ac63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Female</topic><topic>Goiter, Nodular - complications</topic><topic>Humans</topic><topic>Male</topic><topic>MicroRNAs</topic><topic>Neoplasm Recurrence, Local - genetics</topic><topic>Proteomics</topic><topic>Proto-Oncogene Proteins B-raf - genetics</topic><topic>Proto-Oncogene Proteins c-ret - genetics</topic><topic>ras Proteins - genetics</topic><topic>Review</topic><topic>Thyroid Cancer, Papillary - diagnosis</topic><topic>Thyroid Cancer, Papillary - genetics</topic><topic>Thyroid Cancer, Papillary - therapy</topic><topic>Thyroid Neoplasms - diagnosis</topic><topic>Thyroid Neoplasms - genetics</topic><topic>Thyroid Neoplasms - therapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Abdullah, Mardiaty Iryani</creatorcontrib><creatorcontrib>Junit, Sarni Mat</creatorcontrib><creatorcontrib>Ng, Khoon Leong</creatorcontrib><creatorcontrib>Jayapalan, Jaime Jacqueline</creatorcontrib><creatorcontrib>Karikalan, Barani</creatorcontrib><creatorcontrib>Hashim, Onn Haji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdullah, Mardiaty Iryani</au><au>Junit, Sarni Mat</au><au>Ng, Khoon Leong</au><au>Jayapalan, Jaime Jacqueline</au><au>Karikalan, Barani</au><au>Hashim, Onn Haji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations</atitle><jtitle>International journal of medical sciences</jtitle><addtitle>Int J Med Sci</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>16</volume><issue>3</issue><spage>450</spage><epage>460</epage><pages>450-460</pages><issn>1449-1907</issn><eissn>1449-1907</eissn><abstract>Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher</pub><pmid>30911279</pmid><doi>10.7150/ijms.29935</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1449-1907
ispartof International journal of medical sciences, 2019-01, Vol.16 (3), p.450-460
issn 1449-1907
1449-1907
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6428975
source MEDLINE; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Female
Goiter, Nodular - complications
Humans
Male
MicroRNAs
Neoplasm Recurrence, Local - genetics
Proteomics
Proto-Oncogene Proteins B-raf - genetics
Proto-Oncogene Proteins c-ret - genetics
ras Proteins - genetics
Review
Thyroid Cancer, Papillary - diagnosis
Thyroid Cancer, Papillary - genetics
Thyroid Cancer, Papillary - therapy
Thyroid Neoplasms - diagnosis
Thyroid Neoplasms - genetics
Thyroid Neoplasms - therapy
title Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A07%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Papillary%20Thyroid%20Cancer:%20Genetic%20Alterations%20and%20Molecular%20Biomarker%20Investigations&rft.jtitle=International%20journal%20of%20medical%20sciences&rft.au=Abdullah,%20Mardiaty%20Iryani&rft.date=2019-01-01&rft.volume=16&rft.issue=3&rft.spage=450&rft.epage=460&rft.pages=450-460&rft.issn=1449-1907&rft.eissn=1449-1907&rft_id=info:doi/10.7150/ijms.29935&rft_dat=%3Cproquest_pubme%3E2197900345%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2197900345&rft_id=info:pmid/30911279&rfr_iscdi=true